645 related articles for article (PubMed ID: 23208168)
41. Course of erosive gastroesophageal reflux disease (ERD)--a prospective examination under therapeutic daily life conditions with a mean follow-up of 6.5 years.
Hartmann D; Kudis V; Jakobs R; Riemann JF; Schilling D
Z Gastroenterol; 2006 Oct; 44(10):1039-42. PubMed ID: 17063432
[TBL] [Abstract][Full Text] [Related]
42. Reflux disease and Barrett's esophagus.
Koop H
Endoscopy; 2000 Feb; 32(2):101-7. PubMed ID: 10696837
[TBL] [Abstract][Full Text] [Related]
43. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
Tack J; Koek G; Demedts I; Sifrim D; Janssens J
Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
[TBL] [Abstract][Full Text] [Related]
44. [Symptoms in patients with adenocarcinoma of the esophagus].
Leers J; Bollschweiler E; Hölscher AH
Z Gastroenterol; 2005 Mar; 43(3):275-80. PubMed ID: 15765300
[TBL] [Abstract][Full Text] [Related]
45. [Clinical aspects of gastroesophageal reflux disease in elderly patients: results of a 5-year prospective study].
Tsukanov VV; Onuchina EV; Vasyutin AV; Butorin NN; Amelchugova OS
Ter Arkh; 2014; 86(2):23-6. PubMed ID: 24772503
[TBL] [Abstract][Full Text] [Related]
46. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
47. [Gastroesophageal reflux disease].
Gräter H
Praxis (Bern 1994); 2005 Nov; 94(48):1899-906. PubMed ID: 16353687
[TBL] [Abstract][Full Text] [Related]
48. Gastroesophageal reflux disease: epidemiological data, symptomatology and risk factors.
Pelechas E; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):183-8. PubMed ID: 24505912
[TBL] [Abstract][Full Text] [Related]
49. Update in the diagnosis of gastroesophageal reflux disease.
Tutuian R
J Gastrointestin Liver Dis; 2006 Sep; 15(3):243-7. PubMed ID: 17013449
[TBL] [Abstract][Full Text] [Related]
50. Gastroesophageal Reflux Disease: A Review.
Maret-Ouda J; Markar SR; Lagergren J
JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
[TBL] [Abstract][Full Text] [Related]
51. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
52. Recent developments in esophageal adenocarcinoma.
Lagergren J; Lagergren P
CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
[TBL] [Abstract][Full Text] [Related]
53. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?
Lagergren J
Gastrointest Endosc; 2008 Nov; 68(5):856-8. PubMed ID: 18984099
[No Abstract] [Full Text] [Related]
54. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
55. Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma.
Shaheen NJ; Provenzale D
Adv Intern Med; 2001; 47():137-57. PubMed ID: 11795073
[No Abstract] [Full Text] [Related]
56. Features of symptomatic gastroesophageal reflux disease in elderly patients.
Triadafilopoulos G; Sharma R
Am J Gastroenterol; 1997 Nov; 92(11):2007-11. PubMed ID: 9362181
[TBL] [Abstract][Full Text] [Related]
57. Debate: endoscopy is unnecessary in the management of uncomplicated GERD.
Heading RC; Spechler S; Malfertheiner P
Drugs Today (Barc); 2006 Jul; 42 Suppl B():15-21. PubMed ID: 16986067
[TBL] [Abstract][Full Text] [Related]
58. Management of gastroesophageal reflux disease.
Liu JJ; Saltzman JR
South Med J; 2006 Jul; 99(7):735-41; quiz 742, 752. PubMed ID: 16866056
[TBL] [Abstract][Full Text] [Related]
59. The frequency of Barrett's esophagus in high-risk patients with chronic GERD.
Westhoff B; Brotze S; Weston A; McElhinney C; Cherian R; Mayo MS; Smith HJ; Sharma P
Gastrointest Endosc; 2005 Feb; 61(2):226-31. PubMed ID: 15729230
[TBL] [Abstract][Full Text] [Related]
60. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
